FDA official: CDER warning letters up 50% in FY 2025
Regulatory NewsJoanne S. Eglovitch
Audit/inspectionBiologics/ biosimilars/ vaccinesPharmaceuticalsUnited StatesWarning lettersRegulatory NewsJoanne S. EglovitchAudit/inspectionBiologics/ biosimilars/ vaccinesPharmaceuticalsUnited StatesWarning letters